Human ABL1 deficiency syndrome (HADS) is a recognizable syndrome distinct from ABL1-related congenital heart defects and skeletal malformations syndrome

Hum Genet. 2024 Jun;143(6):739-745. doi: 10.1007/s00439-024-02677-y. Epub 2024 May 14.

Abstract

Germline gain of function variants in the oncogene ABL1 cause congenital heart defects and skeletal malformations (CHDSKM) syndrome. Whether a corresponding ABL1 deficiency disorder exists in humans remains unknown although developmental defects in mice deficient for Abl1 support this notion. Here, we describe two multiplex consanguineous families, each segregating a different homozygous likely loss of function variant in ABL1. The associated phenotype is multiple congenital malformations and distinctive facial dysmorphism that are opposite in many ways to CHDSKM. We suggest that a tight balance of ABL1 activity is required during embryonic development and that both germline gain of function and loss of function variants result in distinctively different allelic congenital malformation disorders.

Publication types

  • Case Reports

MeSH terms

  • Abnormalities, Multiple / genetics
  • Female
  • Germ-Line Mutation
  • Heart Defects, Congenital* / genetics
  • Humans
  • Male
  • Pedigree
  • Phenotype
  • Proto-Oncogene Proteins c-abl* / genetics
  • Syndrome

Substances

  • Proto-Oncogene Proteins c-abl
  • ABL1 protein, human